The case underlies the two different concentrations: (1) to forecast a financial plan for pharmaceuticals in view of morbidity patterns, required drug regimens, and unit cost, and to explore the ways in which the budget may be cut in case it exceeds the available cash, and (2) to draw a framework for the analysis of breakeven for the community pharmacies.